Cassia Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-421
| Closed | -$300K | – | 59 |
|
|
2024
Q4 | $300K | Sell |
421
-330
| -44% | -$235K | 0.19% | 56 |
|
|
2024
Q3 | $789K | Sell |
751
-64
| -8% | -$67.3K | 0.52% | 30 |
|
|
2024
Q2 | $857K | Buy |
815
+38
| +5% | +$39.9K | 0.56% | 26 |
|
|
2024
Q1 | $748K | Buy |
777
+156
| +25% | +$150K | 0.5% | 33 |
|
|
2023
Q4 | $545K | Buy |
621
+32
| +5% | +$28.1K | 0.45% | 33 |
|
|
2023
Q3 | $485K | Buy |
589
+13
| +2% | +$10.7K | 0.4% | 31 |
|
|
2023
Q2 | $414K | Buy |
576
+204
| +55% | +$147K | 0.33% | 50 |
|
|
2023
Q1 | $306K | Sell |
372
-9
| -2% | -$7.4K | 0.25% | 45 |
|
|
2022
Q4 | $275K | Buy |
381
+2
| +0.5% | +$1.44K | 0.23% | 62 |
|
|
2022
Q3 | $261K | Buy |
379
+23
| +6% | +$15.8K | 0.24% | 36 |
|
|
2022
Q2 | $210K | Hold |
356
| – | – | 0.21% | 50 |
|
|
2022
Q1 | $249K | Buy |
356
+8
| +2% | +$5.6K | 0.2% | 49 |
|
|
2021
Q4 | $220K | Buy |
+348
| New | +$220K | 0.15% | 60 |
|